Financement

Acknowledgements

Funding from The National Institute of Child Health and Human Development (USA) supports the infrastructure of the Cochrane Neonatal Review Group and allows the preparation and continuous updating of our Cochrane systematic reviews and specialized register.

Dr. Arne Ohlsson was the original coordinator of our hand searching activities. He is no longer able to continue in this particular role, but continues on as an invaluable member of the Cochrane Neonatal Review Group (CNRG). In addition to his role in the CNRG, he was also Director of the Canadian Cochrane Centre until January 2005.

Collaboration with the Cochrane Pregnancy & Childbirth Review Group continues. Communication and sharing of information between our editorial groups is a valuable asset.

Prof. Malcolm Levene served as Regional Coordinator, UK/Europe for the Neonatal Review Group until August 1999. Unfortunately he was unable to continue in this role. He promoted the Cochrane agenda in UK/Europe as well as helped to identify reviewers and support them in their efforts.

Prof. Andrew Whitelaw served as Regional Coordinator, UK/Europe for the Neonatal Review Group until May 2003. Unfortunately he was unable to continue in this role. Prof. Whitelaw was one of our earlier reviewers, with several reviews in our module. His contributions have been greatly valued both as a reviewer and supporter of our activities.

Ms. Sandra Costa served as Trials Search Coordinator for the Neonatal Review Group 1996-2001.
Mrs. Bharati Purohit served as Trials Search Coordinator for the Neonatal Review Group 2001-2006.
Both Sandra and Bharati were active contributors to the work of the Neonatal Review Group. In particular, their work in the development and ongoing management of our Specialized Register and hand searching activities was invaluable.

Les fonctions centrales de la Collaboration Cochrane sont financées par les redevances de la maison d’édition John Wiley & Sons Limited, qui proviennent des ventes d’abonnements à la Bibliothèque Cochrane. Les entités individuelles de la Collaboration Cochrane sont financées par divers organismes gouvernementaux, institutionnels et privés; elles sont liées par une politique transorganisationnelle limitant l’utilisation de fonds provenant de sociétés commanditaires. Les demandes de renseignements visant le financement peuvent être adressées au Chef de la direction .